# Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)

Study · id `cardio:ct-nct07706075` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07706075](<https://clinicaltrials.gov/study/NCT07706075>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07706075

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT07706075. Randomized; single masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2027-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT07706075, source copy `cardio:ctgov-nct07706075-2026-08-03`, retrieved 2026-10-26)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT07706075, source copy `cardio:ctgov-nct07706075-2026-08-03`, retrieved 2026-10-26)
- Primary completion: 2027-07-01 (anticipated) (ClinicalTrials.gov record NCT07706075, source copy `cardio:ctgov-nct07706075-2026-08-03`, retrieved 2026-10-26)
- Completion: 2027-08-01 (anticipated) (ClinicalTrials.gov record NCT07706075, source copy `cardio:ctgov-nct07706075-2026-08-03`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07706075-2026-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Fibrillation With Rapid Ventricular Response
- Intervention (Drug): Verapamil Hydrochloride
- Intervention (Drug): Metoprolol tartrate
- Lead sponsor: Muhammad Ali Javed
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Verapamil (`cardio:verapamil`)

## Provenance

Content hash: 158607125a4fa7e4cb55429b7d6798c779b16ca5e24de8f76dc1bfc07a72fd57
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
